MedWell Ai Reports 280% Quarterly Revenue Growth in Fiscal Q2 2025

February 23rd, 2026 3:45 PM
By: Newsworthy Staff

MedWell Ai announced significant financial improvements including 280% quarterly revenue growth and reduced operating losses, reflecting progress in its AI-driven healthcare strategy.

MedWell Ai Reports 280% Quarterly Revenue Growth in Fiscal Q2 2025

MedWell Ai, Inc. (OTCQB: MWAI) announced the filing of its Form 10-Q for the quarter ended Dec. 31, 2025, reporting revenue of $548,315 for the fiscal second quarter, up more than 280% from $142,861 in the prior-year period. The company also reported six-month revenue of $1,075,806, representing growth of more than 700% year-over-year. These substantial revenue increases coincide with improved financial metrics across several areas, indicating meaningful progress in the company's strategic direction.

Beyond revenue growth, MedWell Ai reported reduced operating losses for both the three- and six-month periods. The company achieved lower general and administrative expenses and improved net loss per share during these periods. Additionally, MedWell Ai reduced its liabilities to $468,655 from $805,500 as of June 30, 2025. These financial improvements collectively reflect the company's advancement in its AI-driven pharmaceutical, healthcare and wellness portfolio strategy.

The company operates through several subsidiaries that form its business operations. MedWell USA, LLC focuses on B2B distribution and e-commerce ordering portals for pharmaceutical products, targeting medical offices, wellness clinics, gyms and online telemedicine companies. MedWell Direct, LLC, operating as TeleMD.Ai, develops and operates B2B and B2C telemedicine platforms that connect consumers, corporations and employees with licensed healthcare providers. MedWell Facilities, LLC concentrates on developing and managing real estate opportunities designed to attract health and wellness tenants, alongside an AI-driven software platform aimed at optimizing operational models for various healthcare clinics through a licensing model.

Additional corporate information is available through the company's websites, including its corporate site at https://www.medwellai.com and its e-commerce B2B product ordering portal at https://www.medwellusa.com. The announcement was distributed through AINewsWire, a specialized communications platform focusing on artificial intelligence advancements within the Dynamic Brand Portfolio at IBN. AINewsWire provides various distribution services including access to wire solutions, article syndication to thousands of outlets, enhanced press release features, social media distribution, and tailored corporate communications solutions. The platform aims to help companies reach investors, influencers, consumers, journalists and the general public through targeted distribution channels.

Source Statement

This news article relied primarily on a press release disributed by InvestorBrandNetwork (IBN). You can read the source press release here,

blockchain registration record for the source press release.
;